Neonatal convulsions are preferably treated with intravenous phenobarbital that contains propylene glycol (PG) as solvent. Very high concentrations of brain PG have been observed with quantitative MRS, especially when low-concentrated phenobarbital medication was used. PG can have serious adverse effects, and the half-life is longer in neonates than in adults. Based on given medication and the interval until MRS examination we estimated a PG half-life in neonatal brain that is at least 30 hours and maybe up to 43 hours. This shows that extremely high and potentially toxic PG concentrations will persist longer than expected in the neonatal brain.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords